New hope for failing lungs: scientists test Double-Drug attack on deadly scarring
NCT ID NCT03939520
Summary
This study tested whether combining two approved lung-scarring (IPF) drugs works better than switching to the other drug alone for patients whose disease keeps getting worse. It involved 279 adults whose lung function declined despite already taking one of the standard medications. Researchers compared continuing the same drug, switching to the other drug, or taking both drugs together over 24 weeks to see which best slowed lung decline and was best tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROGRESSIVE IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP - HP - Hôpital Avicenne
Bobigny, France
-
APHP - Hôpital Xavier Bichat-Claude Bernard
Paris, France
-
CHRU Hôpital Cavale Blanche
Brest, France
-
CHRU de Besançon - Hôpital Jean Minjoz
Besançon, France
-
CHRU de Lille - Hôpital Albert Calmette
Lille, France
-
CHRU de Montpellier - Hôpital Arnaud de Villeneuve
Montpellier, France
-
CHRU, Tours - Hôpital Bretonneau
Tours, France
-
CHU - Hôpital G.R. Laennec
Nantes, France
-
CHU Dijon Bourgogne - Hôpital François Mitterrand
Dijon, France
-
CHU Nancy - Hôpital Brabois
Vandœuvre-lès-Nancy, France
-
CHU Poitiers
Poitiers, 86021, France
-
CHU Rennes - Hôpital Pontchaillou
Rennes, France
-
CHU d'Angers
Angers, France
-
CHU de Caen - Hôpital de la Côte de Nacre
Caen, France
-
CHU de Marseille - Hôpital Nord
Marseille, France
-
CHU de Nice, Hôpital Pasteur
Nice, France
-
CHU de Toulouse - Hôpital Larrey
Toulouse, France
-
Centre Hospitalier de la côte Basque
Bayonne, France
-
Ch de Cornouaille
Quimper, France
-
Groupe Hospitalier Paris Saint Joseph
Paris, France
-
Hôpital Pneumologique et Cardiovasculaire Louis Pradel
Bron, France
-
Hôpital Robert Schuman
Vantoux, France
Conditions
Explore the condition pages connected to this study.